Video Search Results

   RESULTS 1-1 of 1   
Channel Publishing Options Sort by
Cephalon, Inc., (Nasdaq: CEPH) Receives FDA Approval for TREANDA, Treatment of Indolent Non-Hodgkin's Lymphoma - Video

MultiVu  •  Nov. 03, 2008. 09:47 AM EST

Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma

   RESULTS 1-1 of 1   
Grab Channel
Customize

Content Providers